Total Payments
$60,525
2024 Payments
$44,336
Companies
21
Transactions
97
Medicare Patients
1,357
Medicare Billing
$139,358
Payment Breakdown by Category
Other$42,300 (69.9%)
Research$10,360 (17.1%)
Food & Beverage$4,607 (7.6%)
Travel$3,258 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,300 | 16 | 69.9% |
| Unspecified | $10,360 | 2 | 17.1% |
| Food and Beverage | $4,607 | 70 | 7.6% |
| Travel and Lodging | $3,258 | 9 | 5.4% |
Payments by Type
General
$50,165
95 transactions
Research
$10,360
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $44,096 | 37 | $0 (2024) |
| Cook Research Incorporated | $10,360 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,423 | 17 | $0 (2024) |
| Covidien LP | $459.13 | 7 | $0 (2019) |
| GI Supply, Inc. | $425.23 | 2 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $420.12 | 5 | $0 (2023) |
| Lucid Diagnostics Inc. | $242.31 | 2 | $0 (2023) |
| STERIS CORPORATION | $239.86 | 2 | $0 (2022) |
| ABBVIE INC. | $194.40 | 6 | $0 (2024) |
| Laborie Medical Technologies Corp. | $185.78 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,336 | 47 | Phathom Pharmaceuticals, Inc. ($44,096) |
| 2023 | $3,635 | 13 | Cook Research Incorporated ($1,860) |
| 2022 | $2,233 | 14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,307) |
| 2021 | $8,875 | 3 | Cook Research Incorporated ($8,500) |
| 2019 | $457.58 | 8 | Covidien LP ($358.02) |
| 2018 | $581.91 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($500.00) |
| 2017 | $407.98 | 10 | AbbVie, Inc. ($171.37) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $161.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $106.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $533.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $432.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $143.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $183.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $104.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $872.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $692.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $32.69 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Cook Polypectomy Devices | Cook Research Incorporated | $8,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 383 | 449 | $212,886 | $42,201 |
| 2022 | 10 | 235 | 276 | $138,068 | $25,642 |
| 2021 | 11 | 294 | 339 | $140,449 | $30,847 |
| 2020 | 13 | 445 | 505 | $177,409 | $40,669 |
Total Patients
1,357
Total Services
1,569
Medicare Billing
$139,358
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 77 | 123 | $21,156 | $8,837 | 41.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 45 | 45 | $59,850 | $8,375 | 14.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $38,000 | $3,366 | 8.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 49 | $7,938 | $3,020 | 38.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 29 | $22,620 | $2,525 | 11.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,854 | $2,260 | 33.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $7,200 | $2,129 | 29.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $8,040 | $2,000 | 24.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 25 | $16,275 | $1,843 | 11.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $4,784 | $1,825 | 38.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 28 | 28 | $6,104 | $1,816 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 16 | $3,920 | $1,561 | 39.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $7,370 | $1,490 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 25 | $2,775 | $1,155 | 41.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $39,900 | $5,482 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 72 | $12,384 | $5,091 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 24 | 34 | $8,330 | $3,593 | 43.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $30,000 | $2,719 | 9.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $18,462 | $1,872 | 10.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $5,066 | $1,782 | 35.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $6,840 | $1,496 | 21.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $11,320 | $1,484 | 13.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 26 | $4,212 | $1,438 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 14 | $1,554 | $684.04 | 44.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 73 | 107 | $18,404 | $7,858 | 42.7% |
About Dr. Kenneth Vega, MD
Dr. Kenneth Vega, MD is a Gastroenterology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962479238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Vega, MD has received a total of $60,525 in payments from pharmaceutical and medical device companies, with $44,336 received in 2024. These payments were reported across 97 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,300).
As a Medicare-enrolled provider, Vega has provided services to 1,357 Medicare beneficiaries, totaling 1,569 services with total Medicare billing of $139,358. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Gastroenterology
- Location Columbia, SC
- Active Since 03/04/2006
- Last Updated 09/13/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962479238
Products in Payments
- VOQUEZNA (Drug) $44,096
- XIFAXAN (Drug) $2,711
- RELISTOR (Drug) $500.00
- Barrx (Device) $340.18
- DUPIXENT (Biological) $337.22
- truFreeze (Device) $239.86
- TRULANCE (Drug) $212.10
- SUCRAID (Drug) $129.91
- Humira (Biological) $121.83
- PillCam (Device) $118.95
- Padlock (Device) $97.92
- Trulance (Drug) $93.09
- SUFLAVE (Drug) $41.64
- CREON (Drug) $23.03
- Viekira (Drug) $22.44
- OMVOH (Drug) $21.64
- Mavyret (Drug) $21.58
- ZEPOSIA (Drug) $17.57
- ENTYVIO (Biological) $14.52
- LINX Reflux Management System (Device) $13.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Columbia
Rudrajit Rai, Md, MD
Gastroenterology — Payments: $345,636
Gastroenterology $345,636
Dr. Joseph Meserve, M.d, M.D
Gastroenterology — Payments: $86,610
Gastroenterology $86,610
Bradley Anderson, Md, MD
Gastroenterology — Payments: $57,839
Gastroenterology $57,839
Dr. Robert Mcclure, Md, MD
Gastroenterology — Payments: $53,900
Gastroenterology $53,900
Dr. Michael Williams, Md, MD
Gastroenterology — Payments: $48,728
Gastroenterology $48,728
Mr. Balbir Minhas, Md, MD
Gastroenterology — Payments: $33,515
Gastroenterology $33,515